Introduction This study aimed to determine whether encephalopathy is associated with such
COVID-19 outcomes as disease severity, mortality, respiratory failure, intensive care unit …

The reduced pathogenicity of the omicron BA. 1 sub-lineage compared to earlier variants is
well described, although whether such attenuation is retained for later variants like BA. 5 …

Abstract Coronavirus disease 2019 (COVID-19) is caused by the novel viral pathogen,
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 primarily …

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is commonly
associated with neurological complications. Patients with sickle cell disease are at …

Type 2 diabetes mellitus (T2DM) is a chronic hyperglycemia that causes physiological
dysfunction and failure of various organs. Autonomic neuropathy is one of the most common …

Zusammenfassung Einleitung Im Rahmen einer akuten COVID-19-Infektion (Coronavirus
SARS-CoV‑2 Infektion) treten in 10–60% der Patient: innen Kopfschmerzen auf, die Tage …

Background: Hypercytokinemia, the renin-angiotensin system (RAS), and hypoxia are
implicated in brain morbidity in COVID-19. There is little evidence of direct SARS-CoV-2 …

Introducción La infección por SARS-CoV-2 a nivel mundial ha comprometido cerca de
232.075. 351 personas y ha provocado al menos 4.752. 988 muertes, según datos de la …

Neurological complications of COVID-19 contribute significantly to mortality in the intensive
care unit (ICU). Preventive therapy, though discussed in literature, is limited for COVID-19 …

To date, there are only limited pharmacological treatments to cure AUD and the success rate
is very low. Therefore, new therapeutic routes are warranted. This thesis aims to contribute …